Prevention of sudden cardiac death and implantable cardioverter defibrillators: Understanding the competitive risk!

被引：1

作者：

Rischard, Julien ^{[1
]}

Narayanan, Kumar ^{[2
]}

Garcia, Rodrigue ^{[3
]}

Marijon, Eloi ^{[4
]}

机构：

[1] Hop Europeen Georges Pompidou, Dept Cardiol, Unite Rythmol, F-75015 Paris, France

[2] Medicover, Cardiol Dept, Hyderabad, India

[3] CHU Poitiers, Unite Rythmol, F-86000 Poitiers, France

[4] Hop Europeen Georges Pompidou, Dept Cardiol, Unite Rythmol, 20 Rue Leblanc, F-75908 Paris 15, France

来源：

PRESSE MEDICALE | 2019年 / 48卷 / 12期

关键词：

HEART-FAILURE;

D O I：

10.1016/j.lpm.2019.09.010

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

Sudden cardiac death represents a major public health issue, with up to 50% of the cardiovascular mortality. Coronary artery disease and dilated cardiomyopathy both represent almost 90% of sudden cardiac death burden. Primary prevention using implantable cardioverter defibrillator relies, in this population, on the left ventricle ejection fraction simple measurement. In this paper, we aim to discuss in which extent a better understanding of competing risk situation may help for a better patient selection and eventually for optimizing primary prevention using implantable cardioverter defibrillator.

引用

下载

页码：1401 / 1405

页数：5

共 50 条

[21] Implantable cardioverter-defibrillators and prevention of sudden cardiac death in hypertrophic cardiomyopathy. Results of multicenter registry study of the implantable cardioverter-defibrillators
Lyakishev, A. A.
KARDIOLOGIYA, 2007, 47 (09) : 81 - 82
[22] Sudden death in patients with implantable cardioverter defibrillators: The importance of cardiac annihilation
Mitchell, LB
Pineda, E
Titus, JL
Bartosch, PM
Benditt, DG
CIRCULATION, 1999, 100 (18) : 367 - 367
[23] Hypokalaemia and sudden cardiac death - lessons from implantable cardioverter defibrillators
Maeder, Micha
Rickli, Hans
Sticherling, Christian
Widmer, Regula
Ammann, Peter
EMERGENCY MEDICINE JOURNAL, 2007, 24 (03) : 206 - 208
[24] Sudden cardiac death and implantable cardioverter defibrillators: two modern epidemics?
Katritsis, Demosthenes G.
Josephson, Mark E.
EUROPACE, 2012, 14 (06): : 787 - 794
[25] The role of prophylactic implantable cardioverter defibrillators to prevent sudden cardiac death
Talajic, M
Mitchell, LB
Hadjis, T
CANADIAN JOURNAL OF CARDIOLOGY, 2000, 16 : 26C - 28C
[26] The rote of implantable cardioverter-defibrillators and sudden cardiac death prevention: indications, device selection, and outcome
Goldenberg, Ilan
Huang, David T.
Nielsen, Jens Cosedis
EUROPEAN HEART JOURNAL, 2020, 41 (21) : 2003 - +
[27] Outcomes and costs of implantable cardioverter-defibrillators for primary prevention of sudden cardiac death among the elderly
Groeneved, Peter W.
Farmer, Steven A.
Suh, Janice J.
Matta, Mary Anne
Yang, Feifei
HEART RHYTHM, 2008, 5 (05) : 646 - 653
[28] Sex differences in the use of implantable cardioverter-defibrillators for primary and secondary prevention of sudden cardiac death
Curtis, Lesley H.
Al-Khatib, Sana M.
Shea, Alisa M.
Hammill, Bradley G.
Hernandez, Adrian F.
Schulman, Kevin A.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2007, 298 (13): : 1517 - 1524
[29] Implantable cardioverter-defibrillators in sudden cardiac death prevention: guidelines and clinical practice (literature review)
Talibullin, I., V
Lebedeva, N. B.
BYULLETEN SIBIRSKOY MEDITSINY, 2022, 21 (01): : 183 - 196
[30] Sex, shocks, and survival: Sudden cardiac death prevention with implantable cardioverter defibrillators in women versus men
Lehmann, MH
JOURNAL OF CARDIOVASCULAR ELECTROPHYSIOLOGY, 2002, 13 (06) : 569 - 570

← 1 2 3 4 5 →